Gastroesophageal reflux in the neonate

Area of Science:

• Neonatal medicine
• Pediatric gastroenterology
• Infant health

Background:

• Physiologic gastroesophageal reflux (GER) is common in infants and often resolves as a maturational process.
• Gastroesophageal reflux disease (GERD) in neonates and young infants presents challenges, with incomplete understanding of its pathophysiology and long-term implications, especially in high-risk populations.
• Effective diagnostic and therapeutic strategies are crucial for infants experiencing GER with complications like airway compromise, apnea, or chronic lung disease.

Purpose of the Study:

• To highlight the need for better understanding of GERD in high-risk neonates.
• To emphasize the importance of diagnostic and therapeutic availability for infants with GER and associated respiratory issues.
• To underscore the lack of ideal pharmacologic treatments for GERD and the need for further research.

Main Methods:

• Review of current understanding of GER and GERD in infants.
• Discussion of diagnostic challenges and therapeutic limitations.
• Identification of areas requiring further investigation.

Main Results:

• GER is often maturational, but GERD in neonates, particularly high-risk ones, has poorly understood pathophysiology and long-term consequences.
• Current conservative therapies are insufficient for all cases, and ideal pharmacologic agents with minimal side effects are lacking.
• There is a critical need for studies focusing on precise diagnosis, causal mechanisms, improved feeding strategies, and prevention of GERD-related morbidity.

Conclusions:

• Further research is essential to elucidate the pathophysiology and long-term outcomes of GERD in high-risk neonates.
• Development of targeted diagnostic tools and effective, safe pharmacologic agents for infant GERD is a priority.
• Improved feeding strategies and preventative measures are needed to reduce GERD-related morbidity in infants.